Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01886599 · ClinicalTrials.gov registry record · Phase 1
Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT01886599 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 48 participants.
The verdict
NCT01886599, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of the study is to determine how Asunaprevir is handled by the body of subjects with kidney disease compared with subjects with normal kidney function
Interventions
- DRUG Asunaprevir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01886599
The ClinicalTrials.gov registry entry for NCT01886599 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Asunaprevir is the first listed.
NCT01886599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01886599 about?
NCT01886599 is a clinical study titled "Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease". The purpose of the study is to determine how Asunaprevir is handled by the body of subjects with kidney disease compared with subjects with normal kidney function
What is the current status of trial NCT01886599?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2012-11. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01886599?
The interventions under investigation include: Asunaprevir (DRUG).
Who is sponsoring clinical trial NCT01886599?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.